David Weinmann

David Weinmann joined Sunniva in June 2019 as Global Controller. In addition to the oversight of the accounting functions of Sunniva, as the Interim Chief Financial Officer role he will also be responsible for the administrative, financial and risk management operations of the Company. David has over 20 years of progressively increasing experience in both public and privately held companies with the majority of his career in the biotech and pharmaceutical industries. Prior to joining Sunniva, he worked for Thermo Fisher Scientific, Inc., Accriva Diagnostics, and Ambit Biosciences. He has spent the past few years consulting for companies within the start up, transition, and transaction phase, including, ACEA Biosciences, Inc., Ametek, Inc., and Robo3D Limited. Mr. Weinmann has a Bachelor of Science in Accountancy from San Diego State University.